This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The patient would have left the hospital without her medication, and taken her prescription to be filled at her pharmacy. If it had been a large chain pharmacy, she would have essentially been presented with the option of paying a bill she couldn’t afford — or doing without.
The patient would have left the hospital without her medication, and taken her prescription to be filled at her pharmacy. If it had been a large chain pharmacy, she would have essentially been presented with the option of paying a bill she couldn’t afford — or doing without.
Allowing for the submission of a dossier provides manufacturers with the opportunity to present comprehensive, structured evidence supporting their responses. While the questions have been thoughtfully framed, it is crucial that they are presented in a way that is clear, concise, and easily navigable. Question 36: Dossier Submission.
We believe in the power of high-quality patient engagement that is characterized by sustained, reciprocal communication between patients and decision- makers. The NHC urges CMS to engage collaboratively with MA plans to track the clarity, accuracy, and transparency of marketing materials and communications.
However, the scope and complexity of the proposed rule may present implementation challenges. This includes clear communication about how AI tools are used in clinical and administrative Transparency fosters trust and empowers patients and providers to actively participate in care decisions.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content